Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

CHAD THERAPEUTICS INC (CTU)

Income Statement Business | Geographic

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsMar-31-08Mar-31-07Mar-31-06Mar-31-05Mar-31-04Mar-31-03Mar-31-02Mar-31-01
   10-K10-K10-K/A10-K/A10-K10-K10-K10-K
Revenues:  
    Indonesia  0.20.30.00.0    
    Other  -0.2-0.322.324.3    
Revenues  0.00.022.424.321.519.519.012.4
            Revenue growth   [+] -100.0%-8.0%12.7%10.2%2.8%53.3% 
Cost of goods sold  0.00.015.114.612.812.311.89.7
Gross profit  0.00.07.29.78.77.27.22.7
            Gross margin    32.4%40.0%40.4%37.1%37.7%21.8%
Selling, general and administrative  2.32.56.86.96.46.76.25.1
Research and development  0.80.21.61.51.31.00.80.7
EBITDA   [+]-5.7-2.4-0.71.71.40.31.0-2.2
            EBITDA margin    -3.0%7.0%6.6%1.6%5.4%-17.6%
Depreciation  0.30.40.40.40.40.80.90.9
EBITA  -6.0-2.7-1.11.31.0-0.40.1-3.1
            EBITA margin    -4.8%5.5%4.5%-2.3%0.6%-25.0%
Amortization of intangibles  0.00.00.00.00.0   
EBIT   [+]-6.0-2.8-1.11.31.0-0.40.1-3.1
            EBIT margin    -5.0%5.3%4.5%-2.3%0.6%-25.0%
Interest expense, net   [+]1.5-0.10.00.00.00.0-0.1-0.1
Other income (expense), net  3.00.00.00.00.0   
Pre-tax income  -4.5-2.7-1.11.31.0-0.40.2-3.0
Income taxes  0.01.0-0.4-0.50.00.0-1.00.0
            Tax rate    39.0% 0.0%   
Earnings from continuing ops  -4.5-3.7-0.71.81.0-0.41.2-3.0
Earnings from discontinued ops  -3.60.3      
Net income  -8.6-3.4-0.71.81.0-0.41.2-3.0
            Net margin    -3.0%7.5%4.6%-2.2%6.1%-24.3%
   
Basic EPS   [+]($0.44)($0.36)($0.07)$0.18$0.10($0.04)$0.12($0.30)
Diluted EPS   [+]($0.44)($0.36)($0.07)$0.17$0.10($0.04)$0.11($0.30)
   
Shares outstanding (basic)   [+]10.210.210.110.110.110.110.110.0
Shares outstanding (diluted)   [+]10.210.210.110.610.410.110.410.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy